Member-only story

The Cutting-Edge: Recent Advances in Colorectal Cancer Treatment

Oliver Foster

·5.8k Followers· Follow

Published in Recent Advances In The Treatment Of Colorectal Cancer

6 min read · 3 weeks before

386 View Claps

39 Respond

Save

Listen

In the past, surgery was the only effective treatment for colorectal cancer. But today, a variety of treatments are available, including:

Surgery: Surgery is still the main treatment for colorectal cancer. The type of surgery performed will depend on the stage of the cancer.
Chemotherapy: Chemotherapy is a type of drug treatment that uses chemicals to kill cancer cells. Chemotherapy can be given before surgery to shrink the tumor, or after surgery to kill any remaining cancer cells.
Radiation therapy: Radiation therapy uses high-energy beams of radiation to kill cancer cells. Radiation therapy can be given before surgery to shrink the tumor, or after surgery to kill any remaining cancer cells.
Immunotherapy: Immunotherapy is a type of treatment that uses the body's own immune system to fight cancer. Immunotherapy drugs can help the immune system recognize and attack cancer cells.
Targeted therapy: Targeted therapy is a type of treatment that uses drugs that target specific molecules on cancer cells. Targeted therapy drugs can help to stop the growth of cancer cells and promote their death.
Personalized medicine: Personalized medicine is a type of treatment that uses information about a patient's individual cancer to develop a treatment plan. Personalized medicine can help to identify the best treatment options for each patient.

These advances in treatment have led to a significant improvement in the survival rates of patients with colorectal cancer. In the 1970s, the five-year survival rate for patients with colorectal cancer was only about 50%. Today, the five-year survival rate is over 90%.

Immunotherapy

Recent Advances in the Treatment of Colorectal Cancer

4.5 out of 5

Language	:	English
File size	:	10172 KB
Text-to-Speech	:	Enabled
Screen Reader	:	Supported
Enhanced typesetting	:	Enabled
Print length	:	222 pages

Immunotherapy is a type of treatment that uses the body's own immune system to fight cancer. Immunotherapy drugs can help the immune system recognize and attack cancer cells.

There are a number of different types of immunotherapy drugs, including:

Checkpoint inhibitors: Checkpoint inhibitors are drugs that block the checkpoints on T cells. Checkpoints are molecules that help to prevent the immune system from attacking healthy cells. By blocking the checkpoints, checkpoint inhibitors can help the T cells to kill cancer cells.
Cancer vaccines: Cancer vaccines are designed to stimulate the immune system to recognize and attack cancer cells. Cancer vaccines can be made from a variety of different materials, including cancer cells, proteins from cancer cells, or DNA from cancer cells.
Adoptive cell therapy: Adoptive cell therapy is a type of immunotherapy that uses the patient's own T cells to fight cancer. The T cells are removed from the patient's body, modified in the laboratory to make them more effective at killing cancer cells, and then reinfused into the patient's body.

Immunotherapy is a promising new treatment option for patients with colorectal cancer. Immunotherapy drugs have been shown to be effective in treating both early-stage and advanced-stage colorectal cancer.

Targeted Therapy

Targeted therapy is a type of treatment that uses drugs that target specific molecules on cancer cells. Targeted therapy drugs can help to stop the growth of cancer cells and promote their death.

There are a number of different types of targeted therapy drugs, including:

EGFR inhibitors: EGFR inhibitors are drugs that target the EGFR protein. EGFR is a protein that is found on the surface of cancer cells. By blocking the EGFR protein, EGFR inhibitors can help to stop the growth of cancer cells.
VEGF inhibitors: VEGF inhibitors are drugs that target the VEGF protein. VEGF is a protein that helps to promote the growth of new blood vessels. By blocking the VEGF protein, VEGF inhibitors can help to starve cancer cells of the oxygen and nutrients they need to grow.
BRAF inhibitors: BRAF inhibitors are drugs that target the BRAF protein. BRAF is a protein that is found in some types of cancer cells. By blocking the BRAF protein, BRAF inhibitors can help to stop the growth of cancer cells.

Targeted therapy is a promising new treatment option for patients with colorectal cancer. Targeted therapy drugs have been shown to be effective in treating both early-stage and advanced-stage colorectal cancer.

Personalized Medicine

Personalized medicine is a type of treatment that uses information about a patient's individual cancer to develop a treatment plan. Personalized medicine can help to identify the best treatment options for each patient.

There are a number of different types of personalized medicine tests, including:

Gene expression profiling: Gene expression profiling tests measure the activity of genes in cancer cells. This information can be used to identify the best treatment options for each patient.
Next-generation sequencing: Next-generation sequencing tests can identify mutations in cancer cells. This information can be used to identify the best treatment options for each patient.
Liquid biopsy: Liquid biopsy tests can detect cancer cells in the blood. This information can be used to monitor the response to treatment and to detect recurrence of cancer.

Personalized medicine is a promising new approach to treating colorectal cancer. Personalized medicine can help to identify the best treatment options for each patient and to improve the chances of a successful outcome.

The recent advances in the treatment of colorectal cancer have led to a significant improvement in the survival rates of patients. These advances include the development of new surgical techniques, chemotherapy drugs, radiation therapy techniques, immunotherapy drugs, targeted therapy drugs, and personalized medicine tests. As research continues, even more advances are expected in the future, which will further improve the survival rates of patients with colorectal cancer.

Recent Advances in the Treatment of Colorectal Cancer

4.5 out of 5